We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register to chat with like-minded investors on our interactive forums.
| Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
|---|---|---|---|---|---|
| Circassia Group Plc | LSE:CIR | London | Ordinary Share | GB00BJVD3B28 | ORD 0.08P |
| Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|---|---|
| 0.00 | 0.00% | 34.00 | 33.10 | 34.90 | 0.00 | 01:00:00 |
| Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
|---|---|---|---|---|---|
| 0 | 0 | N/A | 0 |
From May 2019 to May 2024
TIDMCIR
RNS Number : 1204S
Circassia Pharmaceuticals Plc
16 December 2016
Circassia Pharmaceuticals plc
Non-Executive Director Retirement
Oxford, UK - 16 December 2016: Circassia Pharmaceuticals plc ("Circassia" or "the Company"; LSE: CIR), a specialty biopharmaceutical company focused on allergy and asthma, today announces the retirement of Cathrin Petty from its Board, following nearly seven years as a Non-Executive Director.
Dr Francesco Granata, Circassia's Chairman, commented: "On behalf of the Board, I would like to thank Cathrin for her significant contribution to the Company over many years, and we wish her well in her new role as Head of European Healthcare at CVC Capital Partners."
Commenting on her retirement, Cathrin Petty said: "I firmly believe that Circassia is well positioned to achieve its ambition to become a self-sustaining, world-class specialty biopharmaceutical company. Unfortunately, the time commitments of my new role preclude me from contributing further as a Director, but I will continue to follow Circassia's progress keenly."
-Ends-
For further information, please contact:
Circassia Tel: +44 (0)1865 405 560 Steve Harris, Chief Executive Officer Julien Cotta, Chief Financial Officer Rob Budge, Corporate Communications FTI Consulting Tel: +44 (0) 20 3727 1000 Ben Atwell / Simon Conway / Mo Noonan
This information is provided by RNS
The company news service from the London Stock Exchange
END
BOAGGGPCPUPQGCQ
(END) Dow Jones Newswires
December 16, 2016 09:44 ET (14:44 GMT)
1 Year Circassia Chart |
1 Month Circassia Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
